Skip to content

Intermittent PrEP may be a robust strategy for anal sex – vaginal much less certain

Geriatric HIV: living with multiple medical conditions will become the norm as population ages

Lower daily tenofovir dose of 150mg safe and effective in people with moderate renal impairment

Sofosbuvir/ledipasvir raises some antiretroviral levels in HIV/HCV coinfected people

Efavirenz compromises hormonal contraceptive implant

Kimberly Scarsi, University of Nebraska Medical Center, speaking at HIV Glasgow. Image courtesy of HIV Drug Therapy Glasgow 2014 (hivglasgow.org)

High incidence of antiretroviral prescribing errors in Nigeria

Ritonavir the cause of the interaction between telaprevir and ritonavir-boosted atazanavir

Studies look at community vs hospital-based HIV care and medication issues

Elizabeth Neuner from the Cleveland Clinic and HIV Medicine Association chair Michael Horberg, at the ID Week Conference.

New NNRTI MK-1439 interacts with ritonavir but not tenofovir

Matt Anderson of Merck (speaking) with moderators Joseph Eron and Pablo Tebas (seated). Photo by Liz Highleyman, hivandhepatitis.com.